glp-1 receptor agonists should be avoided in patients with MYTH BUSTER #1 “Weight-loss injections like medicines are not safe.” Is this really true? GLP-1 (such as Ozempic®) are among the most discussed anti-obesity medicines today. Unfortunately, misinformation on GLP-1 Agonists For Obesity In
Description
doi:10.1080/09273948.2020.1862606 68
Physiologically Based Pharmacokinetic (PBPK) modeling and simulation approaches: a systematic review of published models, applications, and model verification
The FDA, ADA, and AACE do not support the use of this combination in patients with type 2 diabetes
This leads to mitochondrial damage -- in this case, in cells of the digestive system
Br J Anaesth 126(3):567571
